Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair on Leukotriene and Cytokine Release in Allergic Asthma
NCT00657891Phase 4Completed
- Sponsor
- Creighton University
- Start
- Mar 2007
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in asthma, allergic rhinitis (AR), sponsored by Creighton University. Started Mar 2007; status: completed.
02
Drugs
omalizumab
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00657891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657891.